首页> 外文期刊>Molecular medicine reports >miR-647 and miR-1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer
【24h】

miR-647 and miR-1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer

机译:MiR-647和MiR-1914通过在结直肠癌中下调核因子IX等效地促进癌症进展

获取原文
获取原文并翻译 | 示例
       

摘要

MicroRNAs (miRNAs/miRs) have been investigated as diagnostic and prognostic biomarkers for cancer; however, the significance of miRNAs in colorectal cancer (CRC) remains to be elucidated. The aim of the present study was to determine the genetic profiles of CRC tissue, and screen for miRNAs implicated in CRC cell proliferation and migration. RNA sequencing of 10 paired specimens was performed to for screen genes that were upregulated or downregulated in CRC. miRNA expression in CRC specimens and cell lines was confirmed using qPCR analysis. The significance of indicated miRNAs in CRC cell proliferation and migration was evaluated using MTT and scratch wound-healing assays. Online computational prediction, isobaric tags for relative and absolute quantification analysis and a luciferase reporter assay were applied to determine candidate targeted genes for the miRNAs. RNA-seq data revealed miR-1914 as the most prominent miRNA in CRC specimens. qPCR analysis also suggested that the expression of miR-1914, as well as its counterpart miR-647 were elevated in CRC specimens and cell lines. Suppression of miR-647/1914 using small interfering RNAs inhibited CRC SW480 and SW620 cell proliferation, and migration. Nuclear factor I/X (NFIX) was demonstrated to be a candidate for miR-647/1914 and mediated the oncogenic activity of miR-647/1914. In all, miR-647 and miR-1914 were demonstrated to promote the proliferation and migration of CRC cells by directly targeting NFIX. Therapeutic delivery of siRNAs targeting miR-647/1914 and overexpression of NFIX may be feasible approaches for CRC treatment.
机译:MicroRNAS(MIRNAS / MIRS)被调查为癌症的诊断和预后生物标志物;然而,MiRNA在结肠直肠癌(CRC)中的重要性仍有待阐明。本研究的目的是确定CRC组织的遗传分布,以及涉及CRC细胞增殖和迁移的miRNA的筛选。对CRC中升高或下调的筛选基因进行10个成对标本的RNA测序。使用QPCR分析确认CRC样本和细胞系中的miRNA表达。使用MTT和划伤伤口愈合测定评估所指示的MIRNA在CRC细胞增殖和迁移中的重要性。在线计算预测,用于相对和绝对量化分析的同位素标签和荧光素酶报告分析以确定MIRNA的候选靶向基因。 RNA-SEQ数据显示MIR-1914作为CRC标本中最突出的miRNA。 QPCR分析还表明MIR-1914的表达,以及其对应MIR-647的表达在CRC标本和细胞系中升高。使用小干扰RNA抑制miR-647/1914抑制CRC SW480和SW620细胞增殖和迁移。核因子I / X(NFIX)被证明是MIR-647/1914的候选者,并介导MIR-647/1914的致癌活性。总而言之,MIR-647和MIR-1914被证明通过直接靶向NFIX来促进CRC细胞的增殖和迁移。靶向miR-647/1914的SiRNA的治疗递送和NFIX的过表达可能是CRC治疗的可行方法。

著录项

  • 来源
    《Molecular medicine reports》 |2017年第3期|共11页
  • 作者单位

    Fourth Mil Med Univ Xijing Hosp Dept Digest Surg Xian 710032 Shaanxi Peoples R China;

    Fourth Mil Med Univ Dept Biochem &

    Mol Biol 169 Changle Rd Xian 710032 Shaanxi Peoples R China;

    Shaanxi Univ Chinese Med Affiliated Hosp 2 Dept Neurol Xian 712046 Shaanxi Peoples R China;

    Fourth Mil Med Univ Xijing Hosp Dept Digest Surg Xian 710032 Shaanxi Peoples R China;

    Fourth Mil Med Univ Xijing Hosp Dept Digest Surg Xian 710032 Shaanxi Peoples R China;

    Fourth Mil Med Univ Xijing Hosp Dept Digest Surg Xian 710032 Shaanxi Peoples R China;

    Fourth Mil Med Univ Xijing Hosp Dept Digest Surg Xian 710032 Shaanxi Peoples R China;

    Fourth Mil Med Univ Dept Biochem &

    Mol Biol 169 Changle Rd Xian 710032 Shaanxi Peoples R China;

    Fourth Mil Med Univ Dept Biochem &

    Mol Biol 169 Changle Rd Xian 710032 Shaanxi Peoples R China;

    Fourth Mil Med Univ Xijing Hosp Dept Digest Surg Xian 710032 Shaanxi Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 基础医学;
  • 关键词

    colorectal cancer; miR-647; miR-1914-5p; nuclear factor I/X; proliferation; migration;

    机译:结直肠癌;miR-647;miR-1914-5p;核因子I / x;扩散;迁移;
  • 入库时间 2022-08-19 17:25:09

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号